Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Gestational Diabetes Market In The Coming Years?

In recent times, the gestational diabetes sector has experienced robust expansion. The market is projected to proliferate from a worth of $8.37 billion in 2024 to a value of $9.11 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.9%. Factors such as heightened risk of diabetes, enhanced precision in measuring blood glucose levels, the proliferation of insurance providers, a surge in the number of diabetic patients, and a mounting diabetes populace have contributed to this historic period’s growth.

Anticipations imply a robust expansion of the gestational diabetes market size in the upcoming years, with estimated growth reaching $12.78 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this forecasted growth include an increasing obesity rate, the emerging acceptance of cloud-based project strategies, expanding utilization of relevant devices and applications, a rising trend of diabetes owing to unhealthy lifestyle choices, and heightened public health awareness. The forthcoming period will also witness major trends like digital diabetes management applications, closed-loop control systems, diabetes management technology, enzymatic technology, and cutting-edge medical technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp

What Drivers Are Accelerating Expansion Of The Gestational Diabetes Market?

The rise in obesity is believed to be spurring the expansion of the gestational diabetes market. Such individuals have a body mass index (BMI) of 30 or above, indicative of an excess of body fat that could pose significant health hazards. The increase in obesity is a result of a range of factors including sedentary lifestyles, consumption of high-calorie processed foods, genetic factors, and restricted access to healthy food and exercise opportunities. For obese individuals, treating gestational diabetes is vital as they have a higher risk of insulin resistance and excessive pregnancy weight gain, both of which could cause complications for the mother and child if not properly managed. As per the data provided by the World Health Organization in March 2024, about 1 in 8 people worldwide were obese in 2022, with around 2.5 billion adults over 18 categorized as overweight. This number included 890 million obese individuals. Among adults, 43% were overweight and 16% were obese. Moreover, 37 million children below 5 years old were overweight, while over 390 million children and adolescents between 5-19 years were overweight; 160 million of them were obese. Consequently, the growing obesity rate is a catalyst for the gestational diabetes market.

How Is The Global Gestational Diabetes Market Broken Down By Segment?

The gestational diabetesmarket covered in this report is segmented –

1) By Types: Type A1; Type A2; Other Types

2) By Treatment: Monitoring; Drug Treatment; Non-pharmacological treatment

3) By Administration: Oral; Intravenous; Other Administrations

4) By End User: Hospitals; Clinics; Home Care Settings; Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes; Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes; Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes; Gestational Diabetes With Complications

Which Trends Are Likely To Redefine Growth Paths In The Gestational Diabetes Market?

Key players in the gestational diabetes market are concentrating on innovating and creating advanced technological products like diagnostic kits for gestational diabetes, designed for swift, precise, and user-friendly methods of early detection. The principal function of a gestational diabetes diagnostic kit is to determine blood glucose levels and detect any irregular glucose tolerance in expectant women, which facilitates early detection and control of the disease. For instance, DirectSens GmbH, a biotech firm based in Austria, introduced the XpressGT RUO kit in August 2024. This diagnostic kit is intended to diagnose conditions like gestational diabetes, endometriosis, insulin resistance, and liver ailment by accurately measuring 2-hydroxybutyrate (2-HB) levels present in venous blood, a byproduct of liver’s normal activities. Elevated 2-HB levels are connected to a rise in reductive stress, which is tied to several endocrine and obesity-related disorders including insulin resistance. With compatibility to any existing clinical analyzer and the ability to provide results within just 8 minutes, this kit proves to be a practical and efficient diagnostic solution.

Which Firms Are Making The Biggest Impact In The Gestational Diabetes Market?

Major companies operating in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Gestational Diabetes Market?

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20818&type=smp

Browse Through More Reports Similar to the Global Gestational Diabetes Market 2025, By The Business Research Company

Diabetes Care Devices Market 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Diabetes Therapies Market 2025

https://www.thebusinessresearchcompany.com/report/diabetes-therapies-market

Digital Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model